Labs are Vital(TM) Program Targets Science-Minded Students Through Facebook Social Media Network

AbbottIn an effort to attract young people to the clinical laboratory profession, Labs Are Vital(TM), an initiative sponsored by Abbott, has tapped into Facebook, a popular social networking Web site, to reach out to more than four million students with an interest in life sciences.

A Facebook page, sponsored by Labs Are Vital, will enable interested, career-minded high school and college students to meet clinical lab science students or recent graduates and learn about the benefits and challenges of the profession from their peers.

Recruitment is one of many goals of the Labs Are Vital program. Others include improving the visibility of the clinical lab and demonstrating the value of the lab to the greater healthcare community.

Abbott (NYSE: ABT) has been joined by many of the most influential and professional organizations in the clinical lab, who share these goals, including: Clinical Laboratory Management Association (CLMA), American Society for Clinical Laboratory Science (ASCLS), American Society for Clinical Pathology (ASCP), American Medical Technologists (AMT), American Association of Bioanalysts (AAB), American Association for Clinical Chemistry (AACC), Association of Public Health Laboratories (APHL), and AABB,.

According to statistics compiled by ASCP, there currently may be as many as 40,000 unfilled clinical laboratory jobs in the United States. The shortage of clinical lab scientists is a serious problem, and the stakes are high. According to U.S. Department of Labor projections, approximately 13,800 medical laboratory professionals will be needed every year through 2012 to fill vacant positions. Unfortunately, fewer than 5,000 professionals are graduating from educational programs each year.

Clinical laboratory professionals play a leading role in monitoring health, diagnosing diseases, and assessing the treatment of patients. More than 70 percent of the objective information used to make diagnostic decisions is derived from the clinical lab. This tremendous contribution comes at a great value: most clinical labs take up less than 5 percent of a hospital's operating budget.

Online Scholarship Contest and Other Recruitment Programs:
As part of the Facebook initiative, the Labs Are Vital collaboration is also offering an online scholarship contest for college and high school students. Abbott is joined in this effort by ASCLS, APHL, and Blood Systems, Inc.

Contest entrants must submit a video, advertisement, or T-shirt design that encourages others to consider careers in laboratory medicine. Submissions selected for the semi-finalist category will be available to view online where Facebook members will vote on those that most creatively illustrate why clinical lab science is cutting-edge and how laboratorians make a difference.

Other recruitment activities include the launch of a student-focused Web site, http://www.LabScienceCareers.com, where students can find information on career opportunities and educational programs in clinical lab sciences.

Clinical Lab Careers Video

About Labs Are Vital(TM)
Labs Are Vital is a multi-pronged, multi-year education and awareness program sponsored by Abbott that is designed to highlight the critical role that laboratory professionals play in healthcare and to address the issues facing laboratories today. The program - which includes a public awareness campaign, an Instrument Donation Program, and a variety of Web-based resources for laboratory professionals - focuses attention on the life-saving work clinical laboratory scientists provide in diagnosing disease and improving health outcomes.

Most Popular Now

Therapy using dual immune system cells effectively…

A newly developed immunotherapy that simultaneously uses modified immune-fighting cells to home in on and attack two antigens, or foreign substances, on cancer cells was ...

Cleveland Clinic study suggests steroid nasal spra…

A recent Cleveland Clinic study found that patients who regularly use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including a 20 to 2...

How to develop new drugs based on merged datasets

Polymorphs are molecules that have different molecular packing arrangements despite identical chemical compositions. In a recent paper, researchers at GlaxoSmithKline (GS...

New drug combination effective against SARS-CoV-2 …

More countries with greater resources are opening up for a more normal life. But COVID-19 and the SARS-CoV-2 virus are still a significant threat in large parts of the wo...

Sanofi to focus its COVID-19 development efforts o…

Recent positive interim results of Sanofi's mRNA-based COVID-19 vaccine candidate Phase 1/2 study confirm the company's platform robust capabilities and strategy in mRNA...

Discovery of mechanics of drug targets for COVID-1…

A team of international researchers, including McGill Professor Stéphane Laporte, have discovered the working mechanism of potential drug targets for various diseases suc...

Phase II/III trial shows Ronapreve™ (casirivimab a…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive data from the phase II/III 2066 study, investigating Ronapreve™ (casirivimab and imdevimab) in patients hospit...

Pfizer and BioNTech receive first U.S. FDA Emergen…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the P...

AZD7442 request for Emergency Use Authorization fo…

AstraZeneca has submitted a request to the US Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) for AZD7442, its long-acting antibody (LAAB) com...

Pfizer and BioNTech receive CHMP positive opinion …

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...

Boehringer Ingelheim acquires Abexxa Biologics to …

Boehringer Ingelheim announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology r...

GSK welcomes WHO recommendation for broad roll-out…

GlaxoSmithKline (GSK) plc welcomes and applauds the WHO recommendation for the broader deployment of GSK's RTS,S malaria vaccine to reduce childhood illness and deaths fr...